Replimune Group
REPL
140 hedge funds and large institutions have $949M invested in Replimune Group in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 35 reducing their positions, and 16 closing their positions.
294% more call options, than puts
Call options by funds: $193K | Put options by funds: $49K
80% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 35
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
4% more funds holding
Funds holding: 134 → 140 (+6)
0.44% less ownership
Funds ownership: 95.42% → 94.98% (-0.44%)
26% less capital invested
Capital invested by funds: $1.29B → $949M (-$342M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$33.9M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$22.8M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$14.8M |
| 4 |
BlackRock
New York
|
+$14.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$24.2M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
-$14M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.9M |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$7.41M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$5.82M |
REPL Hedge Fund Activity: Q1 2023 in Review
140 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q1 2023, worth a combined $949M — down 26% from $1.29B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new REPL positions and 16 closed out — a net gain of 7 holders — while 63 added to existing stakes and 35 trimmed.
The largest buyer was State Street, adding an estimated $33.9M. The largest seller was Redmile Group, cutting an estimated $24.2M.
- 140 institutional investors held Replimune Group (REPL) as of Q1 2023, up from 134 in Q4 2022.
- Funds reported $949M of Replimune Group stock for Q1 2023, down 26% quarter-over-quarter.
- 23 funds opened new Replimune Group positions in Q1 2023 and 16 closed out, a net change of +7 holders.
- The largest Replimune Group buyer in Q1 2023 was State Street, an estimated $33.9M added.
- The largest Replimune Group seller in Q1 2023 was Redmile Group, an estimated $24.2M sold.
Based on aggregated 13F filings for Q1 2023.